- Home
- OTLK vs AIRT Comparison
OTLK vs AIRT Comparison
Compare OTLK & AIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- AIRT
- Stock Information
- Founded
- OTLK 2010
- AIRT 1980
- Country
- OTLK United States
- AIRT United States
- Employees
- OTLK N/A
- AIRT N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- AIRT Air Freight/Delivery Services
- Sector
- OTLK Health Care
- AIRT Consumer Discretionary
- Exchange
- OTLK Nasdaq
- AIRT Nasdaq
- Market Cap
- OTLK 48.3M
- AIRT 51.3M
- IPO Year
- OTLK 2016
- AIRT N/A
- Fundamental
- Price
- OTLK $1.77
- AIRT $18.01
- Analyst Decision
- OTLK Strong Buy
- AIRT
- Analyst Count
- OTLK 5
- AIRT 0
- Target Price
- OTLK $10.20
- AIRT N/A
- AVG Volume (30 Days)
- OTLK 689.4K
- AIRT 1.4K
- Earning Date
- OTLK 05-15-2025
- AIRT 06-25-2025
- Dividend Yield
- OTLK N/A
- AIRT N/A
- EPS Growth
- OTLK N/A
- AIRT N/A
- EPS
- OTLK 0.83
- AIRT N/A
- Revenue
- OTLK N/A
- AIRT $298,215,000.00
- Revenue This Year
- OTLK N/A
- AIRT N/A
- Revenue Next Year
- OTLK $288.46
- AIRT N/A
- P/E Ratio
- OTLK $2.12
- AIRT N/A
- Revenue Growth
- OTLK N/A
- AIRT 3.36
- 52 Week Low
- OTLK $0.87
- AIRT $14.56
- 52 Week High
- OTLK $9.25
- AIRT $30.60
- Technical
- Relative Strength Index (RSI)
- OTLK 57.64
- AIRT 53.63
- Support Level
- OTLK $1.55
- AIRT $17.18
- Resistance Level
- OTLK $1.90
- AIRT $18.95
- Average True Range (ATR)
- OTLK 0.18
- AIRT 0.69
- MACD
- OTLK 0.01
- AIRT -0.02
- Stochastic Oscillator
- OTLK 53.10
- AIRT 68.46
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.